Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank77
5Y CAGR-1.0%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
-1.0%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2023 | 42.47% |
| Q4 2022 | 59.24% |
| Q3 2022 | 24.50% |
| Q2 2022 | -88.58% |
| Q1 2022 | 61.22% |
| Q4 2021 | -20.04% |
| Q3 2021 | 34.01% |
| Q2 2021 | -40.44% |
| Q1 2021 | 10.22% |
| Q4 2020 | 17.94% |
| Q3 2020 | -51.01% |
| Q2 2020 | 20.92% |
| Q1 2020 | -3.89% |
| Q4 2019 | -50.28% |
| Q3 2019 | 8.49% |
| Q2 2019 | -48.24% |
| Q1 2019 | 61.08% |
| Q4 2018 | 28.37% |
| Q3 2018 | -599.99% |
| Q2 2018 | 186.90% |
| Q1 2018 | 44.61% |
| Q4 2017 | -52.63% |
| Q3 2017 | 8.59% |
| Q2 2017 | 10.88% |
| Q1 2017 | -31.68% |
| Q4 2016 | 0.07% |
| Q3 2016 | 28.15% |
| Q2 2016 | -160.65% |
| Q1 2016 | -124.39% |
| Q4 2015 | 77.81% |
| Q3 2015 | -698.12% |
| Q2 2015 | 90.82% |
| Q1 2015 | -758.94% |
| Q4 2014 | 74.21% |
| Q3 2014 | -223.86% |
| Q2 2014 | 87.11% |
| Q1 2014 | 29.80% |
| Q4 2013 | -403.99% |
| Q3 2013 | 23.24% |
| Q2 2013 | -264.90% |